PATENT CLAIM ANALYSIS

Application Number: 16145345
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["546", "117000"]

Abstract:
The present invention provides compounds of Formula (I): wherein A, X and Y are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.

Claim (Index 4):
A compound according to  claim 3 or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, or a solvate thereof, wherein: ring A is phenyl substituted with 1 R 2  and 0-3 R 3 ; and alternatively, R 2  and R 3 , together with the carbon atoms to which they are attached, combine to form a 5- to 6-membered carbocyclic or heterocyclic ring comprising carbon atoms and 0-3 heteroatoms selected from N, NR a ,  0 , and S(O) p ; wherein said heterocycle is substituted with 0-2 R 19 .

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.33333
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15756373', '15756367', '15756378', '16099010', '16067619']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8033247612333112
- 35 USC 102 Novelty (BERT): 0.5891536687899551
- Combined Prediction Score: 0.7819076519889756
- Mean Citation Score: 461.02643599999993
- Max Citation Score: 519.0335
- Similarity Product: 431.7600857316851

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test